TrialCritical care (London, England)2005

Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study.

Stefan Jochberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.